Latest European Market News

Temas Resources has engaged a European consultant to elevate its investor awareness across key markets, aiming to strengthen its presence in Germany and broader Europe.

Prospech Limited has significantly increased its Jokikangas project tenure in northern Finland, targeting critical minerals like yttrium and niobium amid soaring European prices. The expansion positions the company strongly within a Tier-1 mining jurisdiction as it plans initial exploration activities.

Memphasys Limited has restructured its leadership by eliminating the CEO role to back a direct-selling global commercialisation strategy for its Felix™ System, anticipating imminent CE Mark approval to enter the European IVF market.

International Graphite Limited projects robust financial returns from its new expandable graphite facility joint venture in Germany, targeting production start in mid-2027 with rapid payback and low capital costs.

Australian Vintage Limited has secured a five-year distribution agreement to represent Invivo's wine portfolio in the UK and Ireland, promising significant revenue and volume growth.

Collins Foods has reported record half-year results driven by strong revenue growth, margin expansion, and operational excellence across its Australian and European markets. The company also raised its profit guidance and declared a higher interim dividend.

Evion Group has landed a significant A$1.5 million order to supply expandable graphite to a major US graphite supply chain company, reinforcing its position as a trusted non-Chinese supplier amid growing demand.

SDI Limited reported a steady FY2025 with a slight profit increase, driven by growth in aesthetic and whitening products and the launch of its new amalgam replacement, Stela. The company also announced plans for a new factory to boost production capacity.

Provaris Energy’s 2025 AGM highlights strategic progress in hydrogen and CO2 storage technologies, focusing on European market expansion and a refined licensing business model.

Little Green Pharma Ltd reported a 9.6% revenue increase to $19.2 million and slashed its net loss by 73% in the half-year ending September 2025, driven by strong growth in European medicinal cannabis markets.

James Hardie Industries reports a 34% jump in Q2 FY26 net sales driven by the AZEK acquisition and European growth, while grappling with margin pressures and integration costs.

ECS Botanics has successfully raised nearly A$2 million through a placement aimed at accelerating its international expansion and product development. The move underscores growing investor confidence in the medicinal cannabis company’s strategic growth plans.